4.7 Article

Development of a Highly Sensitive Device for Counting the Number of Disease-Specific Exosomes in Human Sera

期刊

CLINICAL CHEMISTRY
卷 64, 期 10, 页码 1463-1473

出版社

AMER ASSOC CLINICAL CHEMISTRY
DOI: 10.1373/clinchem.2018.291963

关键词

-

资金

  1. Program of Development of Advanced Measurement and Analysis Systems from Japan Science and Technology Agency
  2. Tailor-made Medical Treatment Program (BioBank Japan Project) of Japan Agency for Medical Research and Development [JP17ek0109166]
  3. AMED-CREST [JP17gm0710010]

向作者/读者索取更多资源

BACKGROUND: Although circulating exosomes in blood play crucial roles in cancer development and progression, difficulties in quantifying exosomes hamper their application for reliable clinical testing. By combining the properties of nanobeads with optical disc technology, we have developed a novel device named the ExoCounter to determine the exact number of exosomes in the sera of patients with various types of cancer. METHOD: In this system, individual exosomes were captured in the groove of an optical disc coated with antibodies against exosome surface antigens. The captured exosomes were labeled with antibody-conjugated magnetic nanobeads, and the number of the labeled exosomes was counted with an optical disc drive. RESULTS: We showed that the ExoCounter could detect specific exosomes derived from cells or human serum without any enrichment procedures. The detection sensitivity and linearity with this system were higher than those with conventional detection methods such as ELISA or flow cytometry. In addition to the ubiquitous exosome markers CD9 and CD63, the cancer-related antigens CD147, carcinoembryonic antigen, and human epidermal growth factor receptor 2 (HER2) were also used to quantify cancer cell line-derived exosomes. Furthermore, analyses of a cross-sectional cohort of sera samples revealed that HER2-positive exosomes were significantly increased in patients with breast cancer or ovarian cancer compared with healthy individuals and those with noncancer diseases. CONCLUSIONS: The ExoCounter system exhibits high performance in the direct detection of exosomes in cell culture and human sera. This method may enable reliable analysis of liquid biopsies. (C) 2018 American Association for Clinical Chemistry

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据